Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Paola Di Nardo, Camilla Lisanti, Mattia Garutti, Silvia Buriolla, Martina Alberti, Roberta Mazzeo & Fabio Puglisi. (2022) Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects. Expert Opinion on Drug Safety 21:11, pages 1341-1355.
Read now
Read now
Mani Iyer Prasanth, Dicson Sheeja Malar, Tewin Tencomnao & James Michael Brimson. (2021) The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer’s. Expert Opinion on Therapeutic Targets 25:5, pages 401-414.
Read now
Read now
Mike Snape, Hyoung-gon Lee, Gemma Casadesus & Mark A Smith. (2009) Cell cycle aberrations in Alzheimer’s disease: a novel therapeutic opportunity. Expert Review of Neurotherapeutics 9:11, pages 1579-1580.
Read now
Read now
Barbara Dunn, Marietta Anthony & Banu Arun. (2002) The search for the ideal SERM. Expert Opinion on Pharmacotherapy 3:6, pages 681-691.
Read now
Read now
Articles from other publishers (40)
Hanan Ahabrach, Nisrin El Mlili, Mayra Alejandra Mafla-España & Omar Cauli. (2023) Hair cortisol concentration associates with insomnia and stress symptoms in breast cancer survivors. International Journal of Psychophysiology 191, pages 49-56.
Crossref
Crossref
Firat Kara, Christine M. Lohse, Anna M. Castillo, Nirubol Tosakulwong, Timothy G. Lesnick, Clifford R. JackJrJr, Ronald C. Petersen, Janet E. Olson, Fergus J. Couch, Kathryn J. Ruddy, Kejal Kantarci & Michelle M. Mielke. (2022)
Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain
MRI
markers of neurodegeneration
. Cancer Medicine 12:3, pages 2805-2817.
Crossref
Crossref
Steven Jett, Niharika Malviya, Eva Schelbaum, Grace Jang, Eva Jahan, Katherine Clancy, Hollie Hristov, Silky Pahlajani, Kellyann Niotis, Susan Loeb-Zeitlin, Yelena Havryliuk, Richard Isaacson, Roberta Diaz Brinton & Lisa Mosconi. (2022) Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Jingjing Zhang & Rui Wang. (2021) Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p. Experimental Gerontology 144, pages 111180.
Crossref
Crossref
Gregory L. Branigan, Maira Soto, Leigh Neumayer, Kathleen Rodgers & Roberta Diaz Brinton. (2020) Association Between Hormone-Modulating Breast Cancer Therapies and Incidence of Neurodegenerative Outcomes for Women With Breast Cancer. JAMA Network Open 3:3, pages e201541.
Crossref
Crossref
Anisha S. Bhounsule, Lokesh Kumar Bhatt, Kedar S. Prabhavalkar & Manisha Oza. (2017) Cyclin dependent kinase 5: A novel avenue for Alzheimer’s disease. Brain Research Bulletin 132, pages 28-38.
Crossref
Crossref
L.-M. Sun, H.-J. Chen, J.-A. Liang & C.-H. Kao. (2016) Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study. QJM 109:2, pages 103-109.
Crossref
Crossref
Elizabeth Hampson & Sarah J. Duff-Canning. (2016) Salivary cortisol and explicit memory in postmenopausal women using hormone replacement therapy. Psychoneuroendocrinology 64, pages 99-107.
Crossref
Crossref
Helena Harder & Valerie Jenkins. 2016. Breast Cancer Survivorship. Breast Cancer Survivorship
235
247
.
Chun-Hung Chang, Shaw-Ji Chen & Chieh-Yu Liu. (2015) Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study. Journal of Affective Disorders 182, pages 44-49.
Crossref
Crossref
Caroline Corbel, Bing Zhang, Annabelle Le Parc, Blandine Baratte, Pierre Colas, Cyril Couturier, Kenneth S. Kosik, Isabelle Landrieu, Véronique Le Tilly & Stéphane Bach. (2015) Tamoxifen Inhibits CDK5 Kinase Activity by Interacting with p35/p25 and Modulates the Pattern of Tau Phosphorylation. Chemistry & Biology 22:4, pages 472-482.
Crossref
Crossref
Nahla E. El-Ashmawy & Rania M. Khalil. (2013) A review on the role of l-carnitine in the management of tamoxifen side effects in treated women with breast cancer. Tumor Biology 35:4, pages 2845-2855.
Crossref
Crossref
Paul Newhouse, Kimberly Albert, Robert Astur, Julia Johnson, Magdalena Naylor & Julie Dumas. (2013) Tamoxifen Improves Cholinergically Modulated Cognitive Performance in Postmenopausal Women. Neuropsychopharmacology 38:13, pages 2632-2643.
Crossref
Crossref
N S Bykanova, E A Pigarova & L K Dzeranova. (2012) Prospects for the use of selective estrogen receptor modulator tamoxifen. Obesity and metabolism 9:1, pages 9-13.
Crossref
Crossref
Sarah L. Berga & Yolanda R. Smith. 2012. Handbook of Neuroendocrinology. Handbook of Neuroendocrinology
551
571
.
C. Schüle, D. Eser, T.C. Baghai, C. Nothdurfter, J.S. Kessler & R. Rupprecht. (2011) Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?. Neuroscience 191, pages 55-77.
Crossref
Crossref
David J. Bonda, Hyun-pil Lee, Wataru Kudo, Xiongwei Zhu, Mark A. Smith & Hyoung-gon Lee. (2010) Pathological implications of cell cycle re-entry in Alzheimer disease. Expert Reviews in Molecular Medicine 12.
Crossref
Crossref
Mark A. EspelandSally A. ShumakerMarian LimacherStephen R. RappTherese B. BeversDavid H. BaradLaura H. CokerSarah A. GaussoinMarcia L. StefanickDorothy S. LanePauline M. MakiSusan M. Resnick. (2010) Relative Effects of Tamoxifen, Raloxifene, and Conjugated Equine Estrogens on Cognition. Journal of Women's Health 19:3, pages 371-379.
Crossref
Crossref
Claudine LegaultPauline M. MakiSusan M. ResnickLaura CokerPatricia HoganTherese B. BeversSally A. Shumaker. (2009) Effects of Tamoxifen and Raloxifene on Memory and Other Cognitive Abilities: Cognition in the Study of Tamoxifen and Raloxifene. Journal of Clinical Oncology 27:31, pages 5144-5152.
Crossref
Crossref
Álvaro Pinto Marín, Andrés Redondo Sánchez, Enrique Espinosa Arranz, Pilar Zamora Auñón & Manuel González Barón. (2009) Adjuvant Chemotherapy for Breast Cancer and Cognitive Impairment. Southern Medical Journal 102:9, pages 929-934.
Crossref
Crossref
Carolyn J. Koonce, Alicia A. Walf & Cheryl A. Frye. (2009) Trilostane exerts antidepressive effects among wild-type, but not estrogen receptor β knockout mice. NeuroReport 20:12, pages 1047-1050.
Crossref
Crossref
Kala VisvanathanRowan T. ChlebowskiPatricia HurleyNananda F. ColMary RopkaDeborah CollyarMonica MorrowCarolyn RunowiczKathleen I. PritchardKaren HagertyBanu ArunJudy GarberVictor G. VogelJames L. WadePowel BrownJack CuzickBarnett S. KramerScott M. Lippman. (2009) American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction. Journal of Clinical Oncology 27:19, pages 3235-3258.
Crossref
Crossref
Christian J. Pike, Jenna C. Carroll, Emily R. Rosario & Anna M. Barron. (2009) Protective actions of sex steroid hormones in Alzheimer’s disease. Frontiers in Neuroendocrinology 30:2, pages 239-258.
Crossref
Crossref
François Bourque, Sherif Karama, Karl Looper & Victor Cohen. (2009) Acute Tamoxifen-Induced Depression and Its Prevention With Venlafaxine. Psychosomatics 50:2, pages 162-165.
Crossref
Crossref
Alessandro M. Minisini, Sara De Faccio, Paola Ermacora, Claudia Andreetta, Rachele Fantinel, Matteo Balestrieri, Andrea Piga & Fabio Puglisi. (2008) Cognitive functions and elderly cancer patients receiving anticancer treatment: A prospective study. Critical Reviews in Oncology/Hematology 67:1, pages 71-79.
Crossref
Crossref
Jesse R. Fann, Anne M. Thomas-Rich, Wayne J. Katon, Deborah Cowley, Mary Pepping, Bonnie A. McGregor & Julie Gralow. (2008) Major depression after breast cancer: a review of epidemiology and treatment. General Hospital Psychiatry 30:2, pages 112-126.
Crossref
Crossref
H. Rozenbaum. (2008) Moduladores selectivos de los receptores de estrógenos (SERM). EMC - Ginecología-Obstetricia 44:2, pages 1-8.
Crossref
Crossref
H. Rozenbaum. (2008) « Selective estrogen receptor modulators » (SERM). EMC - Gynécologie 3:1, pages 1-7.
Crossref
Crossref
Zvezdana Snoj, Maja Primic akelj, Milan Lièina & Peter Pregelj. (2008) Psychosocial correlates of progesterone receptors in breast cancer. Depression and Anxiety, pages n/a-n/a.
Crossref
Crossref
A. Monnier. (2007) Clinical management of adverse events in adjuvant therapy for hormone-responsive early breast cancer. Annals of Oncology 18, pages viii36-viii44.
Crossref
Crossref
Kelly C. Lee, G. Thomas Ray, Enid M. Hunkeler & Patrick R. Finley. (2007) Tamoxifen Treatment and New-Onset Depression in Breast Cancer Patients. Psychosomatics 48:3, pages 205-210.
Crossref
Crossref
Judith L. TurgeonMolly C. CarrPauline M. MakiMichael E. MendelsohnPhyllis M. Wise. (2006) Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies. Endocrine Reviews 27:6, pages 575-605.
Crossref
Crossref
Deborah Mook, Jennifer Felger, Franklynn Graves, Kim Wallen & Mark E. Wilson. (2005) Tamoxifen fails to affect central serotonergic tone but increases indices of anxiety in female rhesus macaques. Psychoneuroendocrinology 30:3, pages 273-283.
Crossref
Crossref
Alicia A Walf, Madeline E Rhodes & Cheryl A Frye. (2004) Antidepressant effects of ERβ-selective estrogen receptor modulators in the forced swim test. Pharmacology Biochemistry and Behavior 78:3, pages 523-529.
Crossref
Crossref
Alessandro Minisini, Gul Atalay, Andrew Bottomley, Fabio Puglisi, Martine Piccart & Laura Biganzoli. (2004) What is the effect of systemic anticancer treatment on cognitive function?. The Lancet Oncology 5:5, pages 273-282.
Crossref
Crossref
K.-A. Phillips & J. Bernhard. (2003) Adjuvant Breast Cancer Treatment and Cognitive Function: Current Knowledge and Research Directions. JNCI Journal of the National Cancer Institute 95:3, pages 190-197.
Crossref
Crossref
Rowan T. ChlebowskiNananda ColEric P. WinerDeborah E. CollyarSteven R. CummingsVictor G. VogelIIIIIIHarold J. BursteinAndrea EisenIsaac LipkusDavid G. Pfister. (2002) American Society of Clinical Oncology Technology Assessment of Pharmacologic Interventions for Breast Cancer Risk Reduction Including Tamoxifen, Raloxifene, and Aromatase Inhibition. Journal of Clinical Oncology 20:15, pages 3328-3343.
Crossref
Crossref
Charlotte Brasic Royeen. (2006) Occupation reconsidered. Occupational Therapy International 9:2, pages 111-120.
Crossref
Crossref
Rowan T. Chlebowski. (2002) Breast Cancer Risk Reduction: Strategies for Women at Increased Risk. Annual Review of Medicine 53:1, pages 519-540.
Crossref
Crossref
MARIETTA ANTHONY, J. KOUDY WILLIAMS & BARBARA K. DUNN. (2006) What Would Be the Properties of an Ideal SERM?. Annals of the New York Academy of Sciences 949:1, pages 261-278.
Crossref
Crossref